Spire Wealth Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.2K Buy
+616
New +$17.3K ﹤0.01% 1485
2022
Q2
Sell
-146
Closed -$10K 2655
2022
Q1
$10K Sell
146
-26
-15% -$1.69K ﹤0.01% 2020
2021
Q4
$12K Sell
172
-177
-51% -$12.9K ﹤0.01% 2297
2021
Q3
$24K Sell
349
-3,035
-90% -$234K ﹤0.01% 1775
2021
Q2
$268K Buy
3,384
+393
+13% +$28.6K 0.01% 821
2021
Q1
$196K Buy
+2,991
New +$184K 0.01% 1072

Other funds holding ATRC

Spire Wealth Management's ATRC Position: Q2 2026 in Review

Spire Wealth Management opened a new position in AtriCure (ATRC) in Q2 2026: 616 shares worth $17.2K. The stake represents ﹤0.01% of the portfolio and ranks #1485 among its holdings. This is a return to the name: Spire Wealth Management previously reported a position in ATRC as recently as Q1 2022.

Spire Wealth Management first reported a position in ATRC in Q1 2021 and has held it in 6 quarters since. The position peaked at $268K in Q2 2021. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Spire Wealth Management held 616 shares of AtriCure worth $17.2K as of Q2 2026.
  • AtriCure was a new Spire Wealth Management position in Q2 2026.
  • AtriCure made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1485 holding.
  • Spire Wealth Management first reported a position in AtriCure in Q1 2021 and has held it in 6 quarters since.
  • Spire Wealth Management's AtriCure position peaked at $268K in Q2 2021.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.